CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

← M86

Chapter 13 - Diseases of the musculoskeletal system and connective tissue (M00-M99)»Other osteopathies (M86-M90)»Other chronic hematogenous osteomyelitis (M86.5)

M86.5

Other chronic hematogenous osteomyelitis

Sub-codes (10)

  • M86.50 Other chronic hematogenous osteomyelitis, unspecified site
  • M86.51 Other chronic hematogenous osteomyelitis, shoulder
  • M86.52 Other chronic hematogenous osteomyelitis, humerus
  • M86.53 Other chronic hematogenous osteomyelitis, radius and ulna
  • M86.54 Other chronic hematogenous osteomyelitis, hand
  • M86.55 Other chronic hematogenous osteomyelitis, femur
  • M86.56 Other chronic hematogenous osteomyelitis, tibia and fibula
  • M86.57 Other chronic hematogenous osteomyelitis, ankle and foot
  • M86.58 Other chronic hematogenous osteomyelitis, other site
  • M86.59 Other chronic hematogenous osteomyelitis, multiple sites

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.